rs370190321
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS1
This summary comes from the ClinGen Evidence Repository: The c.870C>T (NM_000488.4) variant in SERPINC1 does not code for a different amino acid (p.Phe290=). The highest population minor allele frequency in gnomAD v2.1.1 is 0.0003730 (48/128676 alleles) in the European population, which is higher than the ClinGen SERPINC1 threshold ([>0.0002]) for BS1, and therefore meets this criterion (BS1). SpliceAI predicts no splicing impact for this variant meeting BP4. In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Thrombosis Variant Curation Expert Panel for SERPINC1: BP4, BP7. LINK:https://erepo.genome.network/evrepo/ui/classification/CA1251325/MONDO:0013144/084
Frequency
Consequence
NM_000488.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINC1 | NM_000488.4 | c.870C>T | p.Phe290Phe | synonymous_variant | 5/7 | ENST00000367698.4 | NP_000479.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPINC1 | ENST00000367698.4 | c.870C>T | p.Phe290Phe | synonymous_variant | 5/7 | 1 | NM_000488.4 | ENSP00000356671.3 | ||
SERPINC1 | ENST00000487183.1 | n.521C>T | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000215 AC: 54AN: 250916Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135564
GnomAD4 exome AF: 0.000471 AC: 688AN: 1460726Hom.: 0 Cov.: 34 AF XY: 0.000465 AC XY: 338AN XY: 726670
GnomAD4 genome AF: 0.000237 AC: 36AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74338
ClinVar
Submissions by phenotype
Hereditary antithrombin deficiency Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Likely benign, reviewed by expert panel | curation | Clingen Thrombosis Variant Curation Expert Panel, ClinGen | Aug 16, 2024 | The c.870C>T (NM_000488.4) variant in SERPINC1 does not code for a different amino acid (p.Phe290=). The highest population minor allele frequency in gnomAD v2.1.1 is 0.0003730 (48/128676 alleles) in the European population, which is higher than the ClinGen SERPINC1 threshold ([>0.0002]) for BS1, and therefore meets this criterion (BS1). SpliceAI predicts no splicing impact for this variant meeting BP4. In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Thrombosis Variant Curation Expert Panel for SERPINC1: BP4, BP7. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at